PUBLICATIONS · 32877599
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2020 Sep 17
- First author
- Dummer R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dummer R
- type
- Author
- name
- Hauschild A
- type
- Author
- name
- Santinami M
- type
- Author
- name
- Atkinson V
- type
- Author
- name
- Mandalà M
- type
- Author
- name
- Kirkwood JM
- type
- Author
- name
- Chiarion Sileni V
- type
- Author
- name
- Larkin J
- type
- Author
- name
- Nyakas M
- type
- Author
- name
- Dutriaux C
- type
- Author
- name
- Haydon A
- type
- Author
- name
- Robert C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dummer R
- type
- Author
- name
- Hauschild A
- type
- Author
- name
- Santinami M
- type
- Author
- name
- Atkinson V
- type
- Author
- name
- Mandalà M
- type
- Author
- name
- Kirkwood JM
- type
- Author
- name
- Chiarion Sileni V
- type
- Author
- name
- Larkin J
- type
- Author
- name
- Nyakas M
- type
- Author
- name
- Dutriaux C
- type
- Author
- name
- Haydon A
- type
- Author
- name
- Robert C
- type
- Author
- bibliography ids
- nci-bib-6130298f55252b2c21ef455a
- book metadata
- content sha256
- b481ebbe2ebbcd9aef34af6149cf8c0bef9aed61a970f3cda86c43d6ee5b506d
- document type
- citation
- dois
- 10.1056/NEJMoa2005493
- electronic publication date
- display
- 2020 Sep 2
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32877599
- immutable id
- pubmed:32877599@b481ebbe2ebbcd9aef34af6149cf8c0bef9aed61a970f3cda86c43d6ee5b506d
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 12
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 1139-1148
- volume
- 383
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32877599
- provenance
- batch id
- 9bca82d1bba2b27adc79
- provider
- NCBI PubMed ESummary
- record sha256
- c274dbbdc1cb04cc6a82ecc90b890a666519539b46e0cb1af232ec3ed67778f3
- response sha256
- c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
- retrieved at
- 2026-09-09T23:47:56.131551+00:00
- publication date
- display
- 2020 Sep 17
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Preserved source evidence · Not medical advice
Triangle